Navigation Links
George Institute receives Gates Foundation grant to survey funding flows
Date:3/20/2008

A team of international health experts is launching a major study to track global funding for research and development (R&D) for neglected diseases in developing countries by surveying global public, private and philanthropic investments. As funding for R&D for neglected diseases has increased, donors do not have a complete overview of how much is currently being spent and on what diseases, which makes determining funding gaps difficult. The George Institute for International Health received a 5 year $US8.8 million grant from the Bill & Melinda Gates Foundation to collect and report global investment into R&D for neglected diseases.

Too often, global health funders must base substantial R&D investment decisions on out-of-date, unreliable information. They lack information about how much or where to invest, or how their investments sit in the context of overall funding flows and priorities, said Dr Mary Moran, Project Leader at the George Institute. By providing an updated and in depth overview, we hope to help donors around the world determine where their investments are most needed, and prevent duplication of effort she added.

Annually for a five year period, The George Institute will survey and analyse public and private global funders, intermediaries and developers, collecting data through an online survey. The survey will examine all aspects of product R&D funding from basic research, through discovery and development, to post-registration activities that support product introduction. It will measure R&D investment into new drugs, vaccines, diagnostics, microbicides and other tools for tropical diseases such as malaria and sleeping sickness, as well as developing-country strains of global diseases such as pneumonia, meningitis and HIV/AIDS, which are often overlooked by product developers that typically prioritize industrialized country markets.

We hope that better information about global funding for R&D for neglected diseases will encourage new investments, and help ensure they are targeted for maximum impact, said Dr. Regina Rabinovich, Director of Infectious Diseases Development at the Gates Foundation.

The project maintains The George Institutes focus on delivering quality public health outcomes. The George Institute for International Health is a multinational not-for-profit research organisation with offices in Australia, China, India and the United Kingdom. The Institute works towards improvement and development of global health through undertaking high quality research, and applying this research to health policy and practice. Given its widely acknowledged work on neglected disease product pipelines and funding, the Health Policy Division of the George Institute is uniquely placed to deliver such an important and vital project.


'/>"/>

Contact: Emma Orpilla
eorpilla@thegeorgeinstitute.org
61-299-934-592
Research Australia
Source:Eurekalert

Related medicine news :

1. Mothers Know Best: NFL Moms Team With Eddie George to Showcase a Better Way to a Healthier Lifestyle
2. Live Webcast With President George H.W. Bush as Bono and DATA Are Honored With National Constitution Centers 2007 Liberty Medal in Historic Philadelphia
3. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
4. George Mason University professor receives $2.6 million NIH grant to study Alzheimers disease
5. New USAID grant helps Georgetown meet unmet family planning needs worldwide
6. CNS Response, Inc. Appoints George C. Carpenter IV to Position of President
7. Reunion with patient inspires follow-up study on treatment for DiGeorge syndrome
8. Georgetown leads major effort to combat disparities in DC stroke care
9. Skinvisible Appoints Dr. George Korkos to Its Advisory Board
10. George Harrison Fund for UNICEF Announces Donation for Bangladesh Cyclone Relief
11. DaVita Nurse Gives Keynote Speech to St. Georges Hospital Vascular Access Annual Meeting in London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 21, 2017 , ... Northern California Medical ... recently joined their multi-specialty medical group. The dermatology practice provides general dermatologic treatment, ... excited to add this excellent dermatology practice to our group’s medical services,” explains ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Spectrum Aquatics Launches New ADA Portable Motion ... deck space. Since the lift is mounted on wheels, it can be wheeled out of ... down kit, to fasten to the deck. "We have transformed the feedback from customers into ...
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... supplement development, announced it attended the January ECRM trade show to continue the marketing ... technologically advanced vitamin C supplement, known for providing 400 percent better absorption than traditional ...
(Date:1/20/2017)... ... ... International Protein, a company based out of Australia that focuses on developing ... trade show in Hilton Head, SC. , International Protein was founded by Christine ... of products that would elevate her fitness regime. At this ECRM trade show, Envall ...
(Date:1/20/2017)... ... , ... “Mary Magdalene: Grace is Greater than Sin”: a unique and ... Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the creation of published ... with countless women who had little knowledge of the female characters portrayed in the ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... 20, 2017 ResMed (NYSE: RMD ), BMC ... Winter Haven, Florida ) today announced they have agreed on ... 3B will be permitted to sell their existing products in exchange ... settlement payment to 3B to close the Florida ... an admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... 20, 2017  Today, during a plenary ... Pathways in Immunology, Growth Disorders and Cancer," ... INFI ) presented preclinical data for ... selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). Preclinical data showed ... resistance to checkpoint inhibition by remodeling the ...
(Date:1/20/2017)... Research and Markets has announced the addition of the ... Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, Liver Panel, Renal ... report to their offering. ... The global clinical laboratory testing market is expected ... innovative solutions on the grounds of maximum efficiency and minimum error ...
Breaking Medicine Technology: